KLK8 and early-onset autosomal dominant Alzheimer disease: Notably, recent preclinical studies by Herring and the colleagues demonstrated that antibody-mediated KLK8 inhibition improves neuroplasticity and memory, reduces fear and attenuates Alzheimer's disease pathology in mice 56,57.